News

  • Jan 15, 2018

    Congratulations to the Harper Lab on their recent publication to advance FSHD therapeutics

    Congratulations to Lindsey Wallace and the Scott Harper lab at Nationwide Children’s Hospital for the publication of their paper: “Pre-clinical Safety and Off-Target Studies to Support Translation of AAC-Mediated RNAi Therapy for FSHD” to advance FSHD research towards therapy.

    Wallace LM, Saad NY, Pyne NK, Fowler AM, Eidahl JO, Domire JS, Griffin DA, Herman AC, Sahenk Z, Rodino-Klapac LR, Harper SQ. Mol Ther Methods Clin Dev. 2017 Dec 24;8:121-130. doi: 10.1016/j.omtm.2017.12.005. eCollection 2018 Mar 16. PMID: 29387734.

  • Dec 19, 2017

    NIH funds collaborative research to investigate the role of innate immunity in FSHD

    An R21 grant has been awarded to the labs of Drs. Charles Emerson and Michael Brehm at the UMMS to combine their expertise in FSHD muscle disease and immunology to develop a blood/ muscle xenograft mouse model of FSHD to investigate the role of innate immunity in FSHD muscle pathology and develop immunotherapies to block disease progression.

  • Nov 8, 2017

    Dr. Lawrence Hayward presents his single cell transcriptome studies at a CSH symposium

    Dr. Lawrence Hayward, clinical scientist at the UMMS Wellstone Center, presented a paper entitled "Transcriptome heterogeneity in low-passage myogenic cells from individuals with facioscapulohumeral muscular dystrophy" at the Single Cell Analysis" meeting held in Cold Spring Harbor, NY, September 8-11, 2017.  This paper was a collaborative effort involving Drs. Jennifer Chen, Rene Maehr, and Charles Emerson at the UMMS.

  • Sep 28, 2017

    2017 Wellstone Center Network Conference Held in Dallas, TX

    The Wellstone Centers Networking Conference “Translating Science into Medical Therapies for Muscular Dystrophy” and was held at the UT Southwestern Muscular Dystrophy Research Center, Pickens Medical Education & Conference Center in Dallas, TX on September 28-29, 2017. The meeting was attended by advocacy groups, patients, and families and  directors and scientists from each of the six Wellstone Muscular Dystrophy Cooperative Research Centers, including the UMMS Wellstone. Center scientists shared research findings with the goal of advancing muscular dystrophy research to the clinic through building collaborations and sharing resources.

  • Sep 18, 2017

    Congratulations to Wellstone Center postdocs on the publication of a comprehensive review on FSHD

    The authors of this timely review on the current progress in FSHD disease and therapeutic development are Drs. Alec DeSimone, Anna Pukula, and Angela Lek, postdoctoral fellows in the UMMS Wellstone Program. PMID: 28915324

  • May 12, 2017

    Congratulations to Wellstone's two poster winners!

    Congratulations to the Wellstone two poster winners!  Dr. Angela Lek, postdoc from Dr. Lou Kunkel's lab, entitled "Using genome-wide CRISPR libraries to identify modifiers of FSHD",and Dr. Joceyln Eidahl, post doc from Dr. Scott Harper's lab, entitled "Protein chemistry of myotoxic DUX4" were both poster winners at the 2017 MDA Scientific Conference held in Washington D.C. on March 20-22, 2017

  • Feb 1, 2017

    MDA Awards Dr. Charles Emerson Jr Grant

    The MDA has awarded Dr. Charles Emerson's lab a grant entitled  iPSC-induced skeletal muscle progenitors to study human myogenesis and FSHD".  The project goals are to identify molecular modifiers of FSHD clinical severity through investigations of DUX4 function in induced pluripotent stem cells (iPSC) from infantile and adult onset subjects.